CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

Case Report | Preliminary Clinical Data of CARsgen’s Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

CARsgen Announces Premarket Approval Application of Claudin18.2 Companion Diagnostic Kit Accepted by China’s NMPA

CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology

ASH Preview | CARsgen to Present Results on Allogeneic BCMA CAR-T CT0596 at ASH 2025 Annual Congress

Passing Away of Non-Executive Director

CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025

Preliminary Clinical Data of Allogeneic CD19/CD20 CAR-T Product for Mantle Cell Lymphoma Reported at Academic Conference

CARsgen Therapeutics Announces 2025 Interim Results

ESMO Preview | CARsgen to Present Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025